发布时间：2008.3

摘要

 
This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications Analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the United States, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2012. The report profiles 87 companies including many key and niche players worldwide such as Aker BioMarine ASA, CP Kelco US, Inc., Cyanotech Corp., Elan Corp, FMC Corp., FMC Biopolymers AS, GlycoMar Ltd., Integrin Advanced Biosystems, International Specialty Products Inc., Lonza Group Ltd, MariCal, Marinova, Martek Biosciences Corp., Mera Pharmaceuticals Inc., New England Biolabs Inc., PharmaMar S.A, PML Applications Ltd., Primex Ltd., Prolume Ltd., Sea Run Holdings Inc., and Tequesta Marine Biosciences. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

目录及图表

TABLE OF CONTENTS   
 
  MARINE BIOTECHNOLOGY (Complete Report) Pages : 252   | $3950 
 
 I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 4 $100
 
     Study Reliability And Reporting Limitations.....I-1    
 
     Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2    
 
     Quantitative Techniques & Analytics.....I-3
Product Definitions And Scope Of Study.....I-3
By Product Segment.....I-3
Biomaterials.....I-3
Bioactive Substances.....I-3
Others.....I-3
By End-Use Application.....I-3
Industrial Products.....I-3
Health Care/Biotechnology.....I-3    
 
     Consumer Products.....I-4
Public Services And Infrastructure.....I-4
Others.....I-4    
 
 II. EXECUTIVE SUMMARY 48 $2250
 
    1. Industry Dynamics.....II-1 2  $200  
 
      Market Scorecard.....II-1
Trends and Issues.....II-1
Medical and Industrial Sectors Garner Research Dollars.....II-1 1 $100
 
      Lack of R&D Investment in the Marine Biotech Industry.....II-2
Preserving Marine Ecology: A Prime Concern.....II-2 1 $100
 
    2. Marine Biotechnology ?An Overview.....II-3 25  $1200  
 
      A Curtain Raiser.....II-3
Why are Microorganisms Crucial?.....II-3 1 $100
 
      Brief History.....II-4
Definition.....II-4 1 $100
 
      Sources of Marine Biotech Products.....II-5
Key Marine Sources and Products.....II-5
Select Marine-Derived Products.....II-5 1 $100
 
      Flora and Fauna.....II-6
Protista.....II-6
Bacteria.....II-6
Fungi .....II-6
Types of Marine Biotech Products.....II-6 1 $100
 
      Marine Biomaterials.....II-7
Marine Adhesives.....II-7
Marine Bioactive Substances.....II-7 1 $100
 
      Select Biological Materials and Chemicals Extracted from Marine Organisms.....II-8 1 $100
 
      Select Companies Involved in Supplying Reagents or Nutritional Products from Marine
  Organisms.....II-9
Enzymes.....II-9
Haloperoxidase Enzymes.....II-9 1 $100
 
      Thermostable DNA-Modifying Enzymes.....II-10
Other Marine Products and Processes.....II-10
Marine Biomass.....II-10
Marine Bio-Process.....II-10
Certain Significant Bio-Processes and their Application.....II-10
End-Use Analysis.....II-10
Definition.....II-10 1 $100
 
      Overview.....II-11 1 $100
 
      Application Areas.....II-12
Foods.....II-12
Nutraceuticals.....II-12
Medicine.....II-12
Cosmetics.....II-12 1 $100
 
      Research Tools.....II-13
Processing Technologies.....II-13
New Energy Sources.....II-13
Agriculture.....II-13
Industrial.....II-13 1 $100
 
      Food Safety.....II-14
Environmental Management.....II-14
Bioremediation.....II-14
Marine Biosurfactants.....II-14 1 $100
 
      Select Biosurfactants Produced from Marine Microorganisms.....II-15
Aquaculture and Marine Biotechnology.....II-15 1 $100
 
      Select Companies Carrying Out Genetic Enhancement or Aquaculture Breeding
  Programs.....II-16
Industrial Applications.....II-16
Healthcare.....II-16 1 $100
 
      Select Therapeutic Compounds in the Pipeline.....II-17
Select Marine Diterpenes and Their Biological Activity.....II-17
Select Players Involved in Biosensor/Diagnostic Activity.....II-17
Select Marine-Based Drugs.....II-17
Cytosar-U.....II-17 1 $100
 
      Prialt.....II-18
Yondelis.....II-18
Bryostatin.....II-18
Didemnin B.....II-18
Dehydrodidemnin B.....II-18
Pseudopterosins.....II-18
Bio-Prospecting.....II-18 1 $100
 
      Select Companies Involved in Bioprospecting and Bioscreening for Novel Marine-Based
  Compounds.....II-19
Consumer Products.....II-19
Select Macroalgal Materials and Their Application in Cosmetic Industry.....II-19 1 $100
 
      Public Services and Infrastructure.....II-20
Others.....II-20
Agriculture.....II-20
Mining.....II-20
An Insight into Select Marine-Origin Products.....II-20
Agar .....II-20
Major Seaweeds Used for Extracting Agar and Agarose.....II-20 1 $100
 
      Alginate.....II-21
Astaxanthin.....II-21 1 $100
 
      Select Producers of Natural and Synthetic Astaxanthin.....II-22
Carrageenan.....II-22 1 $100
 
      Chitin and Chitosan.....II-23
Chitin.....II-23
End-use Applications.....II-23 1 $100
 
      Chitosan.....II-24
Select Industrial Applications of Chitosan.....II-24 1 $100
 
      Collagen.....II-25
Salmon Calcitonin.....II-25
Research and Development Activity.....II-25
Medical.....II-25
Research on Natural Products.....II-25 1 $100
 
      Tackling Biotoxins.....II-26
Controlling Oil Spill Damage.....II-26
Preventing Biofouling.....II-26
Antifouling Coatings.....II-26
Coral Reefs Offer Abundant Opportunities.....II-26 2 $200
 
    3. Regional Market Overview.....II-28 6  $600  
 
      United States.....II-28
Market Outlook.....II-28
Overview.....II-28
Aquaculture Biotechnology.....II-28
Rest of World.....II-28
Market Outlook.....II-28 1 $100
 
      Australia.....II-29
Canada.....II-29
China .....II-29 1 $100
 
      Europe.....II-30
United Kingdom.....II-30 1 $100
 
      Norway.....II-31
Overview.....II-31
Market Participants.....II-31
Industrial Applications.....II-31
Pharmaceuticals.....II-31 1 $100
 
      Latin America.....II-32
India .....II-32
Marine Environment Offers Abundant Opportunities for R&D Initiatives.....II-32
Market Participants.....II-32 1 $100
 
      Government Initiatives.....II-33
New Zealand.....II-33 1 $100
 
    4. Recent Industry Activity.....II-34 5  $500  
 
      Aker BioMarine Merges with Natural ASA to Form Aker BioMarine.....II-34
Aker BioMarine Joins Hands with Pronova Biocare.....II-34
ABL Biotech to Establish New R&D Facility.....II-34
Aquapharm Strikes an Agreement with DowpharmaSM.....II-34
MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials for NPI-0052.....II-34
CP Kelco Acquires Gold Millet.....II-34 1 $100
 
      Oman抯 Attempt To Excel in Marine Research.....II-35
Marical Inks an Agreement with ACD.....II-35
PharmaMar Conducts Clinical Testing of Zalypsis ? Anti-tumor Agent.....II-35
Indore Biotech Inputs to Introduce Fungi-Based Biopesticides.....II-35
CP Kelco Merges with Noviant.....II-35 1 $100
 
      Marine Institute, Biotrove, and NUI扴 Cooperative Research on Atlantic Salmon.....II-36
Jinghua Marine Biological Merges with Work Recovery Inc.....II-36
Albany Molecular Research and Alcon Research in Partnership.....II-36
Maryland-Israel Marine Biotechnology Research Program Gains Extension.....II-36
India to Set Up New National Institutions.....II-36 1 $100
 
      European Centre for Marine Biotechnology Inaugurated.....II-37
Diversa Collaborates with OSU.....II-37
PharmaMar Commences Phase I Clinical Trials of PM02734.....II-37
USFDA Confers Orphan Drug Status to PharmaMar抯 Ovarian Cancer Drug,
  YONDELIS?....II-37
PharmaMar Undertakes Phase II Clinical Trials of Aplidin ?for Bladder and Prostate
  Cancers.....II-37
CorMatrix and Cook Biotech Enter into Research Agreement.....II-37 1 $100
 
      Elan Corp Receives European Approval for PRIALT? (Ziconotide).....II-38 1 $100
 
    5. Focus on Select Players.....II-39 6  $600  
 
      Aker BioMarine ASA (Norway).....II-39
CP Kelco US, Inc. (USA).....II-39
Cyanotech Corp. (USA).....II-39
Elan Corp (Ireland).....II-39 1 $100
 
      FMC Corp. (USA).....II-40
FMC Biopolymers AS (Norway).....II-40
GlycoMar Ltd. (UK).....II-40
Integrin Advanced Biosystems (UK).....II-40
International Specialty Products Inc (USA).....II-40 1 $100
 
      Lonza Group Ltd (Switzerland).....II-41
MariCal (USA).....II-41
Marinova (Australia).....II-41 1 $100
 
      Martek Biosciences Corp. (USA).....II-42
Mera Pharmaceuticals Inc (USA).....II-42
New England Biolabs Inc (USA).....II-42
PharmaMar S.A (Spain).....II-42
PML Applications Ltd. (UK).....II-42 1 $100
 
      Primex Ltd (Iceland).....II-43
Prolume Ltd (USA).....II-43
Sea Run Holdings Inc (USA).....II-43 1 $100
 
      Tequesta Marine Biosciences (USA).....II-44 1 $100
 
    6. Global Market Perspective.....II-45     
 
      Table 1: World Recent Past, Current & Future Analysis for Marine Biotechnology by Geographic Region- United States and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart).....II-45

Table 2: World 10-Year Perspective for Marine Biotechnology by Geographic Region- Percentage Breakdown of Dollar Sales for United States and Rest of World Markets for Years 2003, 2007 & 2012.....II-45 1 $300
 
      Table 3: World Recent Past, Current & Future Analysis for Marine Biotechnology by Product Segment- Marine Biomaterials, Marine Bioactive Substances, and Others Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart).....II-46

Table 4: World 10-Year Perspective for Marine Biotechnology by Product Segment- Percentage Breakdown of Dollar Sales for Marine Biomaterials, Marine Bioactive Substances and Other Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart).....II-46 1 $300
 
      Table 5: World Recent Past, Current & Future Analysis for Marine Biotechnology by End-use Application-Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services and Infrastructure and Other Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2012 (includes corresponding Graph/Chart).....II-47 1 $300
 
      Table 6: World 10-Year Perspective for Marine Biotechnology by End-Use Application- Percentage Breakdown of Dollar Sales for Industrial Products, Health Care/ Biotechnology, Consumer Products, Public Services and Infrastructure and Other Markets for Years 2003, 2007 & 2012 (includes corresponding Graph/Chart).....II-48 1 $300
 
 III. COMPETITIVE LANDSCAPE  194 $995
 
     Total Companies Profiled: 87 (including Divisions/Subsidiaries - 95 )
--------------------------------------------------------------------------------Region/Country                 Players
--------------------------------------------------------------------------------
The United States                32
Canada                            4
Japan                             1
Europe                           35
     France                       1
     Germany                      4
     The United Kingdom           6
     Spain                        1
     Rest of Europe              23
Asia-Pacific (Excluding Japan)   21
Middle East                       2